Suzanne E. Dahlberg

Assessment of Resistance Mechanisms and Clinical Implications in Patients With<i>EGFR</i>T790M–Positive Lung Cancer and Acquired Resistance to Osimertinib

Geoffrey R. Oxnard, Yuebi Hu, Kathryn F. Mileham et al. · JAMA Oncology · 2018 · 689 citations · Full text

Medicine, Oncology, Pharmacology +17

<i>MET</i> Exon 14 Mutations in Non–Small-Cell Lung Cancer Are Associated With Advanced Age and Stage-Dependent <i>MET</i> Genomic Amplification and c-Met Overexpression

Mark M. Awad, Geoffrey R. Oxnard, David M. Jackman et al. · Journal of Clinical Oncology · 2016 · 688 citations · Full text

Medicine, Genetics, Oncology +17

Prospective Validation of Rapid Plasma Genotyping for the Detection of<i>EGFR</i>and<i>KRAS</i>Mutations in Advanced Lung Cancer

Adrian G. Sacher, Cloud P. Paweletz, Suzanne E. Dahlberg et al. · JAMA Oncology · 2016 · 567 citations

Medicine, Genetics, Oncology +17

Brain metastases in patients with EGFR -mutated or ALK -rearranged non-small-cell lung cancers

Deepa Rangachari, Norihiro Yamaguchi, Paul A. VanderLaan et al. · Lung Cancer · 2015 · 526 citations · Full text

Medicine, Cancer Biology, Oncology +14

High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemia

Alejandro Gutiérrez, Takaomi Sanda, Ruta Grebliunaite et al. · Blood · 2009 · 438 citations · Full text

Medicine, Molecular Biology, Oncology +14